Sign up to save your podcasts
Or
Share A closer look at pharma's top R&D budgets
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A closer look at pharma's top R&D budgets
In this week’s episode of "The Top Line," Fierce Biotech’s Gabrielle Masson and Darren Incorvaia sit down to discuss a recent special report from Fierce Biotech, ranking the top 10 R&D budgets from 2024.
Did Merck hold on to its 2023 crown? And did any new faces crack this year’s list? Listen to find out!
To learn more about the topics in this episode:
- The top 10 pharma R&D budgets for 2024
This week's episode is brought to you by Cencora.
See omnystudio.com/listener for privacy information.
View all episodes
By Fierce Life Sciences
4
1111 ratings
In this week’s episode of "The Top Line," Fierce Biotech’s Gabrielle Masson and Darren Incorvaia sit down to discuss a recent special report from Fierce Biotech, ranking the top 10 R&D budgets from 2024.
Did Merck hold on to its 2023 crown? And did any new faces crack this year’s list? Listen to find out!
To learn more about the topics in this episode:
- The top 10 pharma R&D budgets for 2024
This week's episode is brought to you by Cencora.
See omnystudio.com/listener for privacy information.
More shows like The Top Line
View all
Planet Money
30,676 Listeners
Motley Fool Money
3,223 Listeners
Exchanges
974 Listeners
Odd Lots
1,902 Listeners
WSJ Tech News Briefing
1,639 Listeners
a16z Podcast
1,100 Listeners
The Readout Loud
324 Listeners
Wall Street Breakfast
1,040 Listeners
Behind the Money
223 Listeners
The Journal.
6,072 Listeners
BioCentury This Week
34 Listeners
Economics Explained
146 Listeners
Biotech Hangout
19 Listeners
The Markets
75 Listeners
WSJ's Take On the Week
146 Listeners